Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

AAM. 2012; 1(3): 65-70


Clinical Study on the Anabolic Potential of Brahma Rasayana in Geriatric Patients

Y K Sharma, Anjana Mishra, Reena Mankotia.




Abstract

The urge to live, the fear of death, the desire of youth, the distaste for old age and the quest for Rejuvenation have always attracted mankind from antiquity to modern times. Ageing is a deleterious, progressive, universal and thus far irreversible process. The cause of morbidity and mortality world over is shifting from communicable diseases a few decades ago to non communicable diseases. A Poly herbal compound Brahma RasÁyana -1 was selected for its anabolic potential as a trial drug. It is constituted of drugs like Àmalaki, Jeevaniya panchmula, BalÁ, Shatavari, Madhuyashti, Gokshura etc. These all drugs have proven anabolic effects.. 23 patients were selected for the trial who were free from major systemic and metabolic ailments. Only 20 patients completed the trial. Brahma RasÁyana -1 was given in the dose of 10gm twice daily with milk for 45 days and follow up done every 15 days. Evaluation was done by means of objective criteria like Body weight, Foot thrust , Muscle strength, grip power, Temperature and laboratory investigations like Hb, TLC, DLC, ESR, FBS, Blood Urea, Serum creatinine etc. Selected subjective criteria were Visual Analogue Scale of well being, Appetite, Sleep, Physical and mental drive, Exertional capacity and Bowel habits. Results were significant in most of the objective and subjective criteria. Results are therefore suggestive of evaluating Brahama RasÁyana-1 further for restorative effects particularly in geriatric age group.

Key words: Jara, Rasayana, Brahama Rasayana, Visual Analogue Scale.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.